Bronchiolitis obliterans syndrome and additional costs of lung transplantation

Chest

Volumn 118, Issue 6, 2000, Pages 1648-1652

  Van den Berg, Jan W K ^a   Van Enckevort, Petra J ^a   Tenvergert, Elisabeth M ^a   Postma, Dirkje S ^a   Van der Bij, Wim ^a   Koëter, Gerard H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Bronchiolitis obliterans; Cost analysis; Lung transplantation

Indexed keywords

ADULT; ARTICLE; BRONCHIOLITIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE COST; HOSPITALIZATION; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; RESOURCE MANAGEMENT; SYNDROME;

EID: 0034541569     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.118.6.1648     Document Type: Article

References (21)

1. Costeffectiveness of lung transplantation in The Netherlands: A scenario analysis
2. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group
3. The Registry of the International Society for Heart and Lung Transplantation: Sixteenth official report-1999
4. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation
5. Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life
6. Technology assessment of the Dutch Lung Transplantation Program
7. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts: International Society for Heart and Lung Transplantation
8. Lifetime costs of lung transplantation: Estimation of incremental costs
9. The friction cost method for measuring indirect costs of disease
10. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation
11. The cost-effectiveness of lung transplantation: A pilot study, University of Washington Medical Center Lung Transplant Study Group
12. Airway obstruction and bronchiolitis obliterans after lung transplantation
13. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation
14. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: Low yield of transbronchial lung biopsy
15. Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung trans plantation
16. New immunosuppressive drugs and lung transplantation: Last or least?
17. Clinical trial of tacrolimus versus cyclosporine in lung transplantation
18. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome
19. FK506 'rescue' immunosuppression for obliterative bronchiolitis after lung transplantation
20. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: Preliminary experience